TELA Bio (TELA) EPS (Basic) Growth (3y) (2021 - 2026)
TELA Bio (TELA) EPS (Basic) Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 17.98% |
| 10 | TELA Bio | 36.19 Mn | 5.76 Mn | 13.94 Mn | 26.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.29% |
| Mar 31, 2026 | 30.97% |
| Dec 31, 2025 | 30.45% |
| Sep 30, 2025 | 33.28% |
| Jun 30, 2025 | 34.19% |
| Mar 31, 2025 | 31.34% |
| Dec 31, 2024 | 57.16% |
| Sep 30, 2024 | 18.70% |
| Jun 30, 2024 | 20.52% |
| Mar 31, 2024 | 28.99% |
| Dec 31, 2023 | -0.66% |
| Sep 30, 2023 | 4.15% |
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | -0.97% |
| Dec 31, 2022 | 48.94% |
| Sep 30, 2022 | 69.55% |
| Jun 30, 2022 | 69.51% |
| Mar 31, 2022 | 69.46% |
| Dec 31, 2021 | 74.21% |
| Sep 30, 2021 | 63.33% |